Explore more publications!

Mongolia Business Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Business Digest.

Press releases published on April 21, 2026

NFTE Announces 2025-2026 World Series of Innovation Impact League Winners
UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Top Trends for Swoon-Worthy Cruise Vacations
NUAI Investors Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit with the Schall Law Firm
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For”
Airia Shortlisted in The 2026 Security Awards
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
North Texas Food Bank Expands Annual Mahjong Fundraiser to Fight Hunger
Bioxtreme Announces Strategic Investment Led by Serra Holding and Introduces Plaxtreme to Accelerate Neurorehabilitation Innovation
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—GSAT, GRTX, WBS, and FORA
Just Published! A Young Chef's Journey Featuring an Enchanted Prosthetic and a Culinary Mystery Await Young Readers In New Release
Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine
MotorCity Casino Hotel Debuts The Wagner, a Fully Reimagined Bar and Lounge at the Heart of the Casino Floor
QuestionPro Acquires Fathom to Lead in AI-Powered Open-Ended Analysis
PINS Investors Have Opportunity to Lead Pinterest, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Writer Christa Couture hits the road for more immersive, accessible Canadian adventures on Season 7 of Postcards From, returning April 29 to AMI-tv and AMI+
ENR FutureTech 2026 Announces Top Speaker Lineup for May 4-6 Return to San Francisco
Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call
Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions